Björklund Pharma

Home
Company
Science & Innovation
Publications
Media
Contact
- Contact Form

Research

Under construction.

Company News

New COVID-19 Research Provides Insights on the Crucial Role of Zinc in Protein Targets of Drugs That Block SARS-CoV-2 Infection
A Possible New Medicine for Multiple Sclerosis?
Thymosin Beta 4 in Dry Eye Syndrome
The Role of Thymosin Beta 4 in COVID-19 Treatment
Zinc Deficiency: A Globally Widespread Ailment

CONEM Autism Research

Zinc, Copper, and Autism Spectrum Disorder
Digestive Enzyme Therapy: A Possible Option in Autism Spectrum Disorder
Vitamin D Deficiency Correlates with Severity of Autism and Shows Improvement with Supplementation
ADHD, Autism, and Phenylketonuria
Serum Zinc and Copper Levels in Autistic Children

Company News

New COVID-19 Research Provides Insights on the Crucial Role of Zinc in Protein Targets of Drugs That Block SARS-CoV-2 Infection
A Possible New Medicine for Multiple Sclerosis?
Thymosin Beta 4 in Dry Eye Syndrome
The Role of Thymosin Beta 4 in COVID-19 Treatment
Zinc Deficiency: A Globally Widespread Ailment

Contact Us

Björklund Pharma AS
Toften 24
8610 Mo i Rana
Norway

Phone: +47 411 11 942
Email: info(at)bjorklundpharma.com

Copyright © 2024 Björklund Pharma AS